Literature DB >> 16258064

Protein synthesis required for long-term memory is induced by PKC activation on days before associative learning.

Daniel L Alkon1, Herman Epstein, Alan Kuzirian, M Catherine Bennett, Thomas J Nelson.   

Abstract

Protein synthesis has long been known to be required for associative learning to consolidate into long-term memory. Here we demonstrate that PKC isozyme activation on days before training can induce the synthesis of proteins necessary and sufficient for subsequent long-term memory consolidation. Bryostatin (Bryo), a macrolide lactone with efficacy in subnanomolar concentrations and a potential therapeutic for Alzheimer's disease, is a potent activator of PKC, some of whose isozymes undergo prolonged activation after associative learning. Under normal conditions, two training events with paired visual and vestibular stimuli cause short-term memory of the mollusc Hermissenda that lasts approximately 7 min. However, after 4-h exposures to Bryo (0.25 ng/ml) on two preceding days, the same two training events produced long-term conditioning that lasted >1 week and that was not blocked by anisomycin (1 mug/ml). Anisomycin, however, eliminated long-term memory lasting at least 1 week after nine training events. Both the nine training events alone and two Bryo exposures plus two training event regimens caused comparably increased levels of the PKC alpha-isozyme substrate calexcitin in identified type B neurons and enhanced PKC activity in the membrane fractions. Furthermore, Bryo increased overall protein synthesis in cultured mammalian neurons by up to 60% for >3 days. The specific PKC antagonist Ro-32-0432 blocked much of this Bryo-induced protein synthesis as well as the Bryo-induced enhancement of the behavioral conditioning. Thus, Bryo-induced PKC activation produces those proteins necessary and sufficient for long-term memory on days in advance of the training events themselves.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16258064      PMCID: PMC1283453          DOI: 10.1073/pnas.0508001102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Neurophysiological substrates of context conditioning in Hermissenda suggest a temporally invariant form of activity-dependent neuronal facilitation.

Authors:  A C Talk; I A Muzzio; L D Matzel
Journal:  Neurobiol Learn Mem       Date:  1999-09       Impact factor: 2.877

2.  Pavlovian conditioning-specific increases of the Ca2+- and GTP-binding protein, calexcitin in identified Hermissenda visual cells.

Authors:  A M Kuzirian; H T Epstein; D Buck; F M Child; T Nelson; D L Alkon
Journal:  J Neurocytol       Date:  2001-12

3.  Two different biological configurations for long-term memory.

Authors:  Herman T Epstein; Alan M Kuzirian; Frank M Child; Daniel L Alkon
Journal:  Neurobiol Learn Mem       Date:  2004-01       Impact factor: 2.877

4.  Simplified analogs of bryostatin with anticancer activity display greater potency for translocation of PKCdelta-GFP.

Authors:  Jeremy L Baryza; Stacey E Brenner; Madeleine L Craske; Tobias Meyer; Paul A Wender
Journal:  Chem Biol       Date:  2004-09

5.  Effect of acetoxycycloheximide and of an acetoxycycloheximide-puromycin mixture on cerebral protein synthesis and memory in mice.

Authors:  L B Flexner; J B Flexner
Journal:  Proc Natl Acad Sci U S A       Date:  1966-02       Impact factor: 11.205

6.  Actinomycin D blocks formation of memory of shock-avoidance in goldfish.

Authors:  B W Agranoff; R E Davis; L Casola; R Lim
Journal:  Science       Date:  1967-12-22       Impact factor: 47.728

7.  Prolonged habituation of the gill-withdrawal reflex in Aplysia depends on protein synthesis, protein phosphatase activity, and postsynaptic glutamate receptors.

Authors:  Youssef Ezzeddine; David L Glanzman
Journal:  J Neurosci       Date:  2003-10-22       Impact factor: 6.167

8.  Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice.

Authors:  René Etcheberrigaray; Mathew Tan; Ilse Dewachter; Cuno Kuipéri; Ingrid Van der Auwera; Stefaan Wera; Lixin Qiao; Barry Bank; Thomas J Nelson; Alan P Kozikowski; Fred Van Leuven; Daniel L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

9.  Identification of two distinct pathways of protein kinase Calpha down-regulation in intestinal epithelial cells.

Authors:  Olga V Leontieva; Jennifer D Black
Journal:  J Biol Chem       Date:  2003-11-24       Impact factor: 5.157

Review 10.  Defining the human targets of phorbol ester and diacylglycerol.

Authors:  Markus Geiger; Oliver A Wrulich; Marcel Jenny; Wolfgang Schwaiger; Hans H Grunicke; Florian Uberall
Journal:  Curr Opin Mol Ther       Date:  2003-12
View more
  33 in total

1.  Insulin promotes neuronal survival via the alternatively spliced protein kinase CδII isoform.

Authors:  André Apostolatos; Shijie Song; Sandra Acosta; Mishka Peart; James E Watson; Paula Bickford; Denise R Cooper; Niketa A Patel
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

2.  Imipramine ameliorates pain-related negative emotion via induction of brain-derived neurotrophic factor.

Authors:  Seiko Yasuda; Mitsuhiro Yoshida; Hirotaka Yamagata; Yasutake Iwanaga; Hiromi Suenaga; Kozo Ishikawa; Masako Nakano; Satoshi Okuyama; Yoshiko Furukawa; Shoei Furukawa; Toshizo Ishikawa
Journal:  Cell Mol Neurobiol       Date:  2014-08-26       Impact factor: 5.046

3.  Developmental chlorpyrifos and methyl parathion exposure alters radial-arm maze performance in juvenile and adult rats.

Authors:  Frank O Johnson; Janice E Chambers; Carole A Nail; Sumalee Givaruangsawat; Russell L Carr
Journal:  Toxicol Sci       Date:  2009-03-17       Impact factor: 4.849

4.  Substitution on the A-ring confers to bryopyran analogues the unique biological activity characteristic of bryostatins and distinct from that of the phorbol esters.

Authors:  Gary E Keck; Yam B Poudel; Dennie S Welch; Matthew B Kraft; Anh P Truong; Jeffrey C Stephens; Noemi Kedei; Nancy E Lewin; Peter M Blumberg
Journal:  Org Lett       Date:  2009-02-05       Impact factor: 6.005

5.  Total synthesis of bryostatin 16 using a Pd-catalyzed diyne coupling as macrocyclization method and synthesis of C20-epi-bryostatin 7 as a potent anticancer agent.

Authors:  Barry M Trost; Guangbin Dong
Journal:  J Am Chem Soc       Date:  2010-11-02       Impact factor: 15.419

6.  Rasagiline is neuroprotective in an experimental model of brain ischemia in the rat.

Authors:  Z Speiser; A Mayk; L Litinetsky; T Fine; A Nyska; E Blaugrund; S Cohen
Journal:  J Neural Transm (Vienna)       Date:  2006-12-21       Impact factor: 3.575

7.  Bryostatin and its synthetic analog, picolog rescue dermal fibroblasts from prolonged stress and contribute to survival and rejuvenation of human skin equivalents.

Authors:  Tapan K Khan; Paul A Wender; Daniel L Alkon
Journal:  J Cell Physiol       Date:  2017-07-11       Impact factor: 6.384

8.  Lead Diversification through a Prins-Driven Macrocyclization Strategy: Application to C13-Diversified Bryostatin Analogues.

Authors:  Paul A Wender; Kelvin L Billingsley
Journal:  Synthesis (Stuttg)       Date:  2013       Impact factor: 3.157

9.  A cellular model of Alzheimer's disease therapeutic efficacy: PKC activation reverses Abeta-induced biomarker abnormality on cultured fibroblasts.

Authors:  Tapan K Khan; Thomas J Nelson; Vishal A Verma; Paul A Wender; Daniel L Alkon
Journal:  Neurobiol Dis       Date:  2009-02-20       Impact factor: 5.996

10.  Translocation of PKC by yessotoxin in an in vitro model of Alzheimer's disease with improvement of tau and β-amyloid pathology.

Authors:  Eva Alonso; Carmen Vale; Mercedes R Vieytes; Luis M Botana
Journal:  ACS Chem Neurosci       Date:  2013-04-08       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.